Bio-Techne (TECH)
NASDAQHealth CareBiotechnologySnapshot 2026-07-07
$70.61-0.44%
Close 2026-07-07 · 1-day change
Reading TECH? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track TECH free→NASDAQHealth CareBiotechnologySnapshot 2026-07-07
Reading TECH? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track TECH free→QuarterlyIQ Insights · TECH
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 1,210.8 | 1,219.6 | 1,159.1 | 1,136.7 | 738.7 | 738.7 | 738.7 | 714.0 | — | 499.0 | 499.0 | 452.2 | 314.6 | 314.6 | 314.6 | 290.0 |
| Total Revenues | — | 1,219.6 | — | — | — | — | — | — | — | 499.0 | 499.0 | 452.2 | 314.6 | 314.6 | 314.6 | 290.0 |
| Cost of Revenues | 424.3 | 429.4 | 389.3 | 366.9 | 255.5 | 255.5 | 255.5 | 240.5 | 162.4 | 162.4 | 162.4 | 145.0 | 78.8 | 78.8 | 78.8 | 65.0 |
| Gross Profit | 786.5 | 790.3 | 769.7 | 769.8 | 483.2 | 483.2 | 483.2 | 473.5 | 336.7 | 336.7 | 336.7 | 307.3 | 235.8 | 235.8 | 235.8 | 224.9 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 535.9 | 588.5 | 466.4 | 378.4 | 260.6 | 260.6 | 260.6 | 264.4 | 140.9 | 140.9 | 140.9 | 119.4 | 41.7 | 41.7 | 41.7 | 35.9 |
| Operating Income | 153.8 | 102.3 | 206.7 | 298.9 | 157.4 | 157.4 | 157.4 | 146.7 | 150.6 | 150.6 | 150.6 | 0.1 | 166.2 | 166.2 | 166.2 | 163.1 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | 11.2 | 19.2 | 19.2 | 19.2 | 21.7 | 1.7 | 1.7 | 1.7 | 1.5 | — | — | — | — |
| Other Non-Operating Income / Expenses | (6.6) | (3.8) | (21.0) | 39.7 | 119.1 | 119.1 | 119.1 | (34.7) | (3.1) | (3.1) | (3.1) | 7.1 | (4.0) | (4.0) | (4.0) | 1.9 |
| EBT, Incl. Unusual Items | 147.1 | 98.5 | 185.7 | 338.7 | 276.5 | 276.5 | 276.5 | 112.0 | 147.5 | 147.5 | 147.5 | 154.2 | 162.2 | 162.2 | 162.2 | — |
| Income Tax Expense | 37.6 | 25.1 | 17.6 | 53.2 | 47.2 | 47.2 | 47.2 | 15.9 | 43.0 | 43.0 | 43.0 | 46.4 | 49.9 | 49.9 | 49.9 | 52.7 |
| Net Income | ||||||||||||||||
| Minority Interest | — | 0.2 | 0.2 | 0.2 | (9.0) | 0.0 | — | — | — | — | — | — | — | — | — | — |
| Net Income | 109.6 | 73.4 | 168.1 | 285.3 | 229.3 | 229.3 | 229.3 | 96.1 | 104.5 | 104.5 | 104.5 | 107.7 | 112.3 | 112.3 | 112.3 | 112.3 |
| Per Share | ||||||||||||||||
| Basic EPS | 0.70 | 0.47 | 1.07 | 1.81 | 6.00 | 6.00 | 6.00 | 2.54 | 2.81 | 2.81 | 2.81 | 2.90 | 3.04 | 3.04 | 3.04 | 3.03 |
| Diluted EPS | 0.70 | 0.46 | 1.05 | 1.76 | 5.82 | 5.82 | 5.82 | 2.47 | 2.80 | 2.80 | 2.80 | 2.89 | 3.04 | 3.04 | 3.04 | 3.02 |
| Revenue per Share | 7.69 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | 0.32 | 0.32 | 0.32 | 1.28 | 1.28 | 1.28 | 1.28 | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 156.3 | 157.5 | 157.7 | 157.2 | 38.2 | 38.2 | 38.2 | 37.8 | 37.2 | 37.2 | 37.2 | 37.1 | 36.9 | 36.9 | 36.9 | 37.1 |
| Diluted Weighted Avg Shares | 157.4 | 159.7 | 160.8 | 161.9 | 39.4 | 39.4 | 39.4 | 38.9 | 37.3 | 37.3 | 37.3 | 37.2 | 37.0 | 37.0 | 37.0 | 37.2 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 212.2 | 318.4 | 406.2 | 240.2 | 240.2 | 240.2 | 224.9 | 193.4 | 193.4 | 193.4 | 37.4 | 178.7 | 178.7 | 178.7 | 171.8 |
| EBIT | 153.8 | 102.3 | 206.7 | 298.9 | 157.4 | 157.4 | 157.4 | 146.7 | 150.6 | 150.6 | 150.6 | 0.1 | 166.2 | 166.2 | 166.2 | 163.1 |
| Effective Tax Rate | 25.5% | 25.5% | 9.5% | 15.7% | 17.1% | 17.1% | 17.1% | 14.2% | 29.2% | 29.2% | 29.2% | 30.1% | 30.7% | 30.7% | 30.7% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.